Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy

Alberto Agarossi, Enrico Ferrazzi, Fabio Parazzini, Carlo Federico Perno, Luciano Ghisoni

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

The aim of this survey was to assess the prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in Italy. The correlation of genotypes with the cytological results was also evaluated. Cervical samples were collected from 9,947 self-referring women for cervical cancer screening. Participants were screened by liquid-based cytology and high-risk HPV testing using the Hybrid Capture 2 test. Positive samples were genotyped by PCR. Samples (1,474; 14.8%) were positive for high-risk HPV. The prevalence was 29.4% in the 15-19 years-group, decreasing progressively to 6.1% at 50-54 years of age and increasing to 12.2% in those aged over 65 years. HPV 16 was the genotype detected most frequently followed by HPV 31, HPV 18, HPV 56, and HPV 51. HPV 16 or 18 were present in 4% of women with normal cytology and both were detected contemporarily in only 14 women. Twenty-two percent of atypical squamous cells, 26% of low-grade and 56% of high-grade squamous intraepithelial lesions at cytology were positive for HPV 16 and/or 18. The prevalence of HPV infection in Italy is in agreement with that reported worldwide. HPV 16 was the prevalent genotype. The concomitant infection with HPV 16 and HPV 18 (vaccine targets) was found rarely. Apart from HPV 16 and 18, there was a substantial presence of HPV genotypes against which the vaccines available currently have shown cross-protection efficacy. The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice.

Original languageEnglish
Pages (from-to)529-535
Number of pages7
JournalJournal of Medical Virology
Volume81
Issue number3
DOIs
Publication statusPublished - Mar 2009

Fingerprint

Papillomavirus Infections
Human papillomavirus 16
Early Detection of Cancer
Uterine Cervical Neoplasms
Italy
Human papillomavirus 18
Genotype
Cell Biology
Papillomavirus Vaccines
Human papillomavirus 31
Cross Protection
Vaccines
Polymerase Chain Reaction
Infection

Keywords

  • Cervical cancer
  • Cervical cytology
  • Genotypes
  • HPV infection
  • Screening

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. / Agarossi, Alberto; Ferrazzi, Enrico; Parazzini, Fabio; Perno, Carlo Federico; Ghisoni, Luciano.

In: Journal of Medical Virology, Vol. 81, No. 3, 03.2009, p. 529-535.

Research output: Contribution to journalArticle

@article{8f3b7c536fea402fa30b745e79d3a193,
title = "Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy",
abstract = "The aim of this survey was to assess the prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in Italy. The correlation of genotypes with the cytological results was also evaluated. Cervical samples were collected from 9,947 self-referring women for cervical cancer screening. Participants were screened by liquid-based cytology and high-risk HPV testing using the Hybrid Capture 2 test. Positive samples were genotyped by PCR. Samples (1,474; 14.8{\%}) were positive for high-risk HPV. The prevalence was 29.4{\%} in the 15-19 years-group, decreasing progressively to 6.1{\%} at 50-54 years of age and increasing to 12.2{\%} in those aged over 65 years. HPV 16 was the genotype detected most frequently followed by HPV 31, HPV 18, HPV 56, and HPV 51. HPV 16 or 18 were present in 4{\%} of women with normal cytology and both were detected contemporarily in only 14 women. Twenty-two percent of atypical squamous cells, 26{\%} of low-grade and 56{\%} of high-grade squamous intraepithelial lesions at cytology were positive for HPV 16 and/or 18. The prevalence of HPV infection in Italy is in agreement with that reported worldwide. HPV 16 was the prevalent genotype. The concomitant infection with HPV 16 and HPV 18 (vaccine targets) was found rarely. Apart from HPV 16 and 18, there was a substantial presence of HPV genotypes against which the vaccines available currently have shown cross-protection efficacy. The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice.",
keywords = "Cervical cancer, Cervical cytology, Genotypes, HPV infection, Screening",
author = "Alberto Agarossi and Enrico Ferrazzi and Fabio Parazzini and Perno, {Carlo Federico} and Luciano Ghisoni",
year = "2009",
month = "3",
doi = "10.1002/jmv.21347",
language = "English",
volume = "81",
pages = "529--535",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy

AU - Agarossi, Alberto

AU - Ferrazzi, Enrico

AU - Parazzini, Fabio

AU - Perno, Carlo Federico

AU - Ghisoni, Luciano

PY - 2009/3

Y1 - 2009/3

N2 - The aim of this survey was to assess the prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in Italy. The correlation of genotypes with the cytological results was also evaluated. Cervical samples were collected from 9,947 self-referring women for cervical cancer screening. Participants were screened by liquid-based cytology and high-risk HPV testing using the Hybrid Capture 2 test. Positive samples were genotyped by PCR. Samples (1,474; 14.8%) were positive for high-risk HPV. The prevalence was 29.4% in the 15-19 years-group, decreasing progressively to 6.1% at 50-54 years of age and increasing to 12.2% in those aged over 65 years. HPV 16 was the genotype detected most frequently followed by HPV 31, HPV 18, HPV 56, and HPV 51. HPV 16 or 18 were present in 4% of women with normal cytology and both were detected contemporarily in only 14 women. Twenty-two percent of atypical squamous cells, 26% of low-grade and 56% of high-grade squamous intraepithelial lesions at cytology were positive for HPV 16 and/or 18. The prevalence of HPV infection in Italy is in agreement with that reported worldwide. HPV 16 was the prevalent genotype. The concomitant infection with HPV 16 and HPV 18 (vaccine targets) was found rarely. Apart from HPV 16 and 18, there was a substantial presence of HPV genotypes against which the vaccines available currently have shown cross-protection efficacy. The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice.

AB - The aim of this survey was to assess the prevalence and distribution of oncogenic human papillomavirus (HPV) genotypes in women who underwent screening for cervical cancer in Italy. The correlation of genotypes with the cytological results was also evaluated. Cervical samples were collected from 9,947 self-referring women for cervical cancer screening. Participants were screened by liquid-based cytology and high-risk HPV testing using the Hybrid Capture 2 test. Positive samples were genotyped by PCR. Samples (1,474; 14.8%) were positive for high-risk HPV. The prevalence was 29.4% in the 15-19 years-group, decreasing progressively to 6.1% at 50-54 years of age and increasing to 12.2% in those aged over 65 years. HPV 16 was the genotype detected most frequently followed by HPV 31, HPV 18, HPV 56, and HPV 51. HPV 16 or 18 were present in 4% of women with normal cytology and both were detected contemporarily in only 14 women. Twenty-two percent of atypical squamous cells, 26% of low-grade and 56% of high-grade squamous intraepithelial lesions at cytology were positive for HPV 16 and/or 18. The prevalence of HPV infection in Italy is in agreement with that reported worldwide. HPV 16 was the prevalent genotype. The concomitant infection with HPV 16 and HPV 18 (vaccine targets) was found rarely. Apart from HPV 16 and 18, there was a substantial presence of HPV genotypes against which the vaccines available currently have shown cross-protection efficacy. The findings of this study may contribute to reliable predictions on the potential efficacy of an HPV vaccine in clinical practice.

KW - Cervical cancer

KW - Cervical cytology

KW - Genotypes

KW - HPV infection

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=60049091316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60049091316&partnerID=8YFLogxK

U2 - 10.1002/jmv.21347

DO - 10.1002/jmv.21347

M3 - Article

C2 - 19152401

AN - SCOPUS:60049091316

VL - 81

SP - 529

EP - 535

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 3

ER -